New needle treatment could replace surgery for adrenal gland tumors

NCT ID NCT05368090

Recruiting now Disease control Sponsor: Haukeland University Hospital Source: ClinicalTrials.gov ↗

First seen May 12, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study tests a new, less invasive procedure called EUS-RFA (using ultrasound and heat) to treat small tumors on the left adrenal gland that cause a hormone disorder (primary aldosteronism) leading to high blood pressure. About 60 adults will receive the new procedure, and their results will be compared to those who have standard surgery to remove the gland. The goal is to see if the new method can control the hormone problem with fewer complications and a shorter hospital stay.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Haukeland University Hospital
RECRUITING

Bergen, 5021, Norway

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ALDOSTERONE-PRODUCING ADENOMA HYPERCORTISOLISM PRIMARY ALDOSTERONISM